Treatment of bipolar disorder: new perspectives (Q37280843)

19 August 2017

1 reference

title

Treatment of bipolar disorder: new perspectives (English)

1 reference

19 August 2017

1 reference

Cynthia Calkin

3

0 references

Tomas Hajek

object named as

Tomas Hajek

series ordinal

2

0 references

Claire O'Donovan

series ordinal

4

object named as

Claire O'Donovan

1 reference

19 August 2017

Martin Alda

1

1 reference

PubMed ID

18821183

19 August 2017

language of work or name

English

0 references

publication date

1 January 2009

1 reference

19 August 2017

1 reference

19 August 2017

41

1 reference

19 August 2017

3

1 reference

19 August 2017

186-196

1 reference

Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians

19 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Excess mortality in bipolar and unipolar disorder in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Pharmacotherapy of bipolar mixed states

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

The long-term natural history of the weekly symptomatic status of bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Pharmacotherapy of bipolar depression: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Evolving trends in the long-term treatment of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Relapse prevention in bipolar disorder: a critical review of current guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

A plea for integrity of the bipolar disorder concept.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

The phenotypic spectra of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Anxious and non-anxious bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Anxiety as a correlate of response to the acute treatment of bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Comorbid bipolar disorder and panic disorder in families with a high prevalence of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Are schizophrenic and bipolar disorders related? A review of family and molecular studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Phenotypic spectra of bipolar disorder in responders to lithium versus lamotrigine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

A consecutive series of treated affected offspring of parents with bipolar disorder: is response associated with the clinical profile?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Spectrum of effectiveness of valproate in neuropsychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Serotonin transporter gene associated with lithium prophylaxis in mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Response to lithium augmentation in depression is associated with the glycogen synthase kinase 3-beta -50T/C single nucleotide polymorphism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Association study of the glycogen synthase kinase-3beta gene polymorphism with prophylactic lithium response in bipolar patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Examination of IMPA1 and IMPA2 genes in manic-depressive patients: association between IMPA2 promoter polymorphisms and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

A possible association between the -116C/G single nucleotide polymorphism of the XBP1 gene and lithium prophylaxis in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Bipolar disorder and myo-inositol: a review of the magnetic resonance spectroscopy findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Structure-based design leads to the identification of lithium mimetics that block mania-like effects in rodents. possible new GSK-3beta therapies for bipolar disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Cellular plasticity cascades: genes-to-behavior pathways in animal models of bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

An open-label trial of riluzole in patients with treatment-resistant major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Preliminary evidence of riluzole efficacy in antidepressant-treated patients with residual depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Antidepressant effects of ketamine in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Bipolar disorder: how far are we from a rigorous definition and effective management?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Neuropsychological performance in depressed and euthymic bipolar patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Does cognition predict community function only in schizophrenia?: a study of schizophrenia patients, bipolar affective disorder patients, and community control subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Neuropsychological dysfunction in bipolar affective disorder: a critical opinion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Long-term treatment with paroxetine increases verbal declarative memory and hippocampal volume in posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Bilateral hippocampal volume increases after long-term lithium treatment in patients with bipolar disorder: a longitudinal MRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Disability and its treatment in bipolar disorder patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

The enduring psychosocial consequences of mania and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Service utilization and social morbidity associated with depressive symptoms in the community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Sustained attention deficit in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Sleep duration as a risk factor for the development of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

A prospective study of sleep duration and coronary heart disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Brain-derived neurotrophic factor (BDNF) and type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Pharmacological inhibitors of glycogen synthase kinase 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Lower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Suggestive Linkage to Chromosomal Regions 13q31 and 22q12 in Families With Psychotic Bipolar Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

Increased Mortality Among Patients Admitted With Major Psychiatric Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802409489

10.1080/07853890802409489

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

18821183